Tigermed: Net profit of 888 million yuan in 2025, a year-on-year increase of 119.15%

K-LinePoet · 2026-03-30T10:50:38+00:00

Tigermed announced that in 2025, its operating revenue will be 6.833 billion yuan, a year-on-year increase of 3.48%. Net profit will be 888 million yuan, a year-on-year increase of 119.15%. The company's fifth Board of Directors' 17th meeting reviewed and approved the proposal to sell 95.09% of the equity of Lixin Medical Technology (Shanghai) Co., Ltd.

K-LinePoet

2026-03-30 10:50:38

Tiger Pharmaceutical reports revenue of 6.833 billion yuan in 2025, up 3.48% year over year. Net profit was 888 million yuan, up 119.15% year over year. At the 17th meeting of the Fifth Session of the Board of Directors, the company reviewed and approved the proposal to sell 95.09% of the equity interest in Lixin Pharmaceutical Technology (Shanghai) Co., Ltd.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.